Molina Healthcare (MOH)
(Delayed Data from NYSE)
$363.22 USD
+1.35 (0.37%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $363.94 +0.72 (0.20%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Molina (MOH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$412.92 | $453.00 | $357.00 | 14.11% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Molina comes to $412.92. The forecasts range from a low of $357.00 to a high of $453.00. The average price target represents an increase of 14.11% from the last closing price of $361.87.
Analyst Price Targets (12)
Broker Rating
Molina currently has an average brokerage recommendation (ABR) of 2.15 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.15 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, six are Strong Buy, representing 46.15% of all recommendations. A month ago, Strong Buy represented 46.15%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 5 |
Sell | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 1 |
ABR | 2.15 | 2.15 | 2.15 | 2.00 | 2.27 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/4/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
2/20/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
12/18/2023 | Mizuho SecuritiesUSA | Ann K Hynes | Not Available | Strong Buy |
10/3/2023 | Stephens | Scott Fidel | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.15 |
ABR (Last week) | 2.15 |
# of Recs in ABR | 13 |
Average Target Price | $412.92 |
LT Growth Rate | 15.10% |
Industry | Medical - HMOs |
Industry Rank by ABR | 200 of 252 |
Current Quarter EPS Est: | 5.46 |